[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL45644A - 3-alkyl-1,9-dihydroxyhexa-hydrodibenzo(b,d)pyran derivatives - Google Patents

3-alkyl-1,9-dihydroxyhexa-hydrodibenzo(b,d)pyran derivatives

Info

Publication number
IL45644A
IL45644A IL45644A IL4564474A IL45644A IL 45644 A IL45644 A IL 45644A IL 45644 A IL45644 A IL 45644A IL 4564474 A IL4564474 A IL 4564474A IL 45644 A IL45644 A IL 45644A
Authority
IL
Israel
Prior art keywords
hydrodibenzo
dihydroxyhexa
alkyl
pyran derivatives
pyran
Prior art date
Application number
IL45644A
Other languages
English (en)
Other versions
IL45644A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL45644A0 publication Critical patent/IL45644A0/xx
Publication of IL45644A publication Critical patent/IL45644A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL45644A 1973-11-05 1974-09-11 3-alkyl-1,9-dihydroxyhexa-hydrodibenzo(b,d)pyran derivatives IL45644A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (2)

Publication Number Publication Date
IL45644A0 IL45644A0 (en) 1974-11-29
IL45644A true IL45644A (en) 1978-03-10

Family

ID=23635420

Family Applications (1)

Application Number Title Priority Date Filing Date
IL45644A IL45644A (en) 1973-11-05 1974-09-11 3-alkyl-1,9-dihydroxyhexa-hydrodibenzo(b,d)pyran derivatives

Country Status (26)

Country Link
US (1) US3968125A (xx)
JP (1) JPS6033835B2 (xx)
AR (1) AR202318A1 (xx)
AT (1) AT336012B (xx)
BE (1) BE821716A (xx)
BG (1) BG26387A3 (xx)
CA (1) CA1023753A (xx)
CH (1) CH605894A5 (xx)
CS (1) CS193507B2 (xx)
DD (1) DD116230A5 (xx)
DE (1) DE2451934C2 (xx)
DK (1) DK136719B (xx)
ES (1) ES431674A1 (xx)
FR (1) FR2249664B1 (xx)
GB (1) GB1487637A (xx)
HU (1) HU169193B (xx)
IE (1) IE40023B1 (xx)
IL (1) IL45644A (xx)
NL (1) NL7414439A (xx)
PH (1) PH11788A (xx)
PL (2) PL93908B1 (xx)
RO (1) RO71766A (xx)
SE (1) SE415762B (xx)
SU (1) SU524517A3 (xx)
YU (1) YU36515B (xx)
ZA (1) ZA745751B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (xx) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
JPWO2003070277A1 (ja) * 2002-02-19 2005-06-09 塩野義製薬株式会社 抗掻痒剤
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
PT2176208E (pt) * 2007-07-30 2015-05-11 Zynerba Pharmaceuticals Inc Pró-fármacos de canabidiol, composições compreendendo pró- fármacos de canabidiol e métodos de utilização dos mesmos
WO2009099670A2 (en) * 2008-02-08 2009-08-13 Nektar Therapeutics Al, Corporation Oligomer-cannabinoid conjugates
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
MY163048A (en) 2009-05-06 2017-08-15 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP3654942A1 (en) 2017-07-20 2020-05-27 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Pharmaceutical film compositions for delivery of lipophilic compounds into and/or across the skin
CN111278425B (zh) 2017-09-11 2024-06-11 耶路撒冷希伯来大学伊萨姆研究开发有限公司 用于向脑部经鼻给药药物和用于全身作用的组合物和方法
WO2019106652A1 (en) 2017-11-29 2019-06-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cannabinoids compositions and methods
CA3116194A1 (en) 2018-11-04 2020-05-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Orally administrable cannabinoids-containing compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
AT336012B (de) 1977-04-12
ATA886374A (de) 1976-08-15
ES431674A1 (es) 1976-11-16
JPS5071678A (xx) 1975-06-13
SU524517A3 (ru) 1976-08-05
DE2451934A1 (de) 1975-05-07
BG26387A3 (bg) 1979-03-15
DD116230A5 (xx) 1975-11-12
AR202318A1 (es) 1975-05-30
IL45644A0 (en) 1974-11-29
DK573274A (xx) 1975-07-07
CS193507B2 (en) 1979-10-31
SE415762B (sv) 1980-10-27
NL7414439A (nl) 1975-05-07
ZA745751B (en) 1976-04-28
YU265874A (en) 1982-02-25
US3968125A (en) 1976-07-06
CA1023753A (en) 1978-01-03
PL93908B1 (xx) 1977-07-30
GB1487637A (en) 1977-10-05
CH605894A5 (xx) 1978-10-13
IE40023B1 (en) 1979-02-28
AU7321274A (en) 1976-03-18
IE40023L (en) 1975-05-05
DK136719B (da) 1977-11-14
HU169193B (xx) 1976-10-28
FR2249664A1 (xx) 1975-05-30
BE821716A (fr) 1975-04-30
PH11788A (en) 1978-07-05
PL95748B1 (pl) 1977-11-30
RO71766A (ro) 1982-12-06
DE2451934C2 (de) 1983-10-06
JPS6033835B2 (ja) 1985-08-05
FR2249664B1 (xx) 1978-03-24
SE7413833L (xx) 1975-05-06
DK136719C (xx) 1978-04-24
YU36515B (en) 1984-02-29

Similar Documents

Publication Publication Date Title
IL45644A (en) 3-alkyl-1,9-dihydroxyhexa-hydrodibenzo(b,d)pyran derivatives
PH11009A (en) Triazolyl-o,n-acetals
PH10463A (en) Aminodibenzo(b,d)pyrans
CA1023385A (en) 5-acetamido-2,4-dimethyltrifluoromethanesulfonanilide
MW1474A1 (en) Coumarin derivatives
IL44859A0 (en) Hydroxycoumarin derivatives
PH10117A (en) Dibenzo(b,e)thiepine derivatives
IL45807A0 (en) Derivatives of 7alpha-methylester-4-ene-3alpha,17beta-diols
ZA744364B (en) 4,3-dihydro-2h-naphthalin-1-one-5-oxypropyl-piperazine derivatives
ZA74932B (en) 7-alkyl-delta3,5-steroids
ZA743304B (en) 17beta-hydroxy-16,16-dimethylestr-4-en-3-one
AU7612874A (en) Benzopyran derivatives
CA1009234A (en) 2-methyl-5-substituted chromones
CA1010882A (en) 5-bromo-5-nitro-2-alkylsubstituted-1,3-dioxane
AU7365674A (en) Coumarin derivatives
GB1407940A (en) 6-aza-1h-1,4-bnezodiazepines
IE39704L (en) Dibenzothiepin and -oxepin derivatives.
IE42215L (en) Azetidinone derivatives.
AU483739B2 (en) Substituted trizzolo-1, 5-benzodiazephines
AU485289B2 (en) AMINODIBENZO I B, d PYRANS
AU478213B2 (en) 17b- hydroxy-16, 16-dimethylester-4-en-3-one
AU479172B2 (en) l, 3-DIOXANS
AU478031B2 (en) 5-bromo-5-nitro-2-alkylsubstituted-1, 3-dioxane
AU482712B2 (en) Substituted benzofurans
AU484880B2 (en) Coumarin derivatives